CARB-X

From WikiMD's Food, Medicine & Wellness Encyclopedia

CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) is a global non-profit partnership dedicated to accelerating early development antibacterial research to tackle the rising global threat of drug-resistant bacteria.

Overview[edit | edit source]

CARB-X was launched in 2016 with the aim of addressing the urgent global problem of antibiotic resistance. It is funded by BARDA (Biomedical Advanced Research and Development Authority), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services, the Wellcome Trust, a global charity based in the UK working to improve health globally, Germany’s Federal Ministry of Education and Research (BMBF), the UK Department of Health and Social Care’s Global Antimicrobial Resistance Innovation Fund (GAMRIF), and the Bill & Melinda Gates Foundation.

Mission[edit | edit source]

The mission of CARB-X is to accelerate a diverse portfolio of at least 20 high-quality antibacterial products towards clinical development by 2021. This includes antibiotics, vaccines, and other therapeutics specifically targeting drug-resistant bacteria.

Projects[edit | edit source]

CARB-X funds projects in the early stages of development, then selects the most promising to receive additional funding. Projects can receive up to $500,000 for exploratory research, and up to $15 million for drug discovery and preclinical development.

Impact[edit | edit source]

Since its inception, CARB-X has built the world’s largest and most innovative pipeline of preclinical products against drug-resistant infections. As of 2020, CARB-X is supporting over 50 active projects in various stages of research around the world.

See also[edit | edit source]

References[edit | edit source]

‎ ‎


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Admin, Prab R. Tumpati, MD